Rate My Professor Danielle Bond

Dr Bond earned her Bachelor of Biomedical Sciences with First Class Honours from the University of Newcastle. Her interests include acute myeloid leukaemia, DNA methylation, epigenetics, myelodysplastic syndromes, pancreatic cancer, prostate cancer, tetraspanins, microRNAs, and multi-omics in cancer genetics. Key publications feature 'Hypomethylating agents induce epigenetic and transcriptional heterogeneity in myeloid malignancies' (2025), 'Upregulated cholesterol biosynthesis facilitates the survival of hypomethylating agent-resistant leukaemia cells' (2024), 'scTEM-seq: Single-cell analysis of transposable element methylation...' (2022), and 'The Olive Biophenols Oleuropein and Hydroxytyrosol Selectively Reduce Proliferation... in Pancreatic Cancer Cells' (2018). She has secured a Faculty of Health and Medicine pilot grant, HMRI CFMEU donor grant, and HMRI Leukaemia Donor Grant (2018). Dr Bond has presented at national and international conferences, published in high-impact journals, served as RHD representative on the school research committee, deputy convenor of the ASMR Newcastle committee, and organised local scientific meetings, while building an independent research program on cancer epigenetic heterogeneity.